Get App Open
In App
Credit Cards
Open App
you are here:

Cohance Lifesciences Ltd.

BSE: 543064 | NSE: COHANCE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE03QK01018 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Sep 29, 16:01
873.65 -2.15 (-0.25%)
Volume
AVERAGE VOLUME
5-Day
17,800
10-Day
17,817
30-Day
23,635
15,986
  • Prev. Close

    875.80

  • Open Price

    876.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Sep 29, 15:49
876.40 7.10 (0.82%)
Volume
AVERAGE VOLUME
5-Day
249,599
10-Day
282,567
30-Day
675,950
445,128
  • Prev. Close

    869.30

  • Open Price

    878.90

  • Bid Price (Qty.)

    876.40 (4)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Cohance Lifesciences (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 1,068.31 1,009.49 1,320.86 1,307.01 995.46  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 1,068.31 1,009.49 1,320.86 1,307.01 995.46  
Total Operating Revenues 1,093.51 1,024.99 1,330.08 1,320.22 1,009.72  
Other Income 53.98 55.09 44.55 187.79 14.24  
Total Revenue 1,147.49 1,080.09 1,374.63 1,508.01 1,023.96  
EXPENSES  
Cost Of Materials Consumed 212.51 248.38 421.36 459.46 310.32  
Purchase Of Stock-In Trade 0.00 0.00 0.00 0.00 0.00  
Operating And Direct Expenses 0.00 127.78 170.87 173.19 122.73  
Changes In Inventories Of FG,WIP And Stock-In Trade 86.53 53.88 -20.94 -60.35 -8.37  
Employee Benefit Expenses 198.30 126.88 100.84 100.48 87.29  
Finance Costs 8.00 7.43 5.39 6.23 9.14  
Depreciation And Amortisation Expenses 57.20 48.79 42.84 39.10 31.64  
Other Expenses 233.60 58.17 74.87 67.46 57.23  
Total Expenses 796.14 671.31 795.24 785.56 609.98  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 351.35 408.77 579.39 722.45 413.98  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 351.35 408.77 579.39 722.45 413.98  
Tax Expenses-Continued Operations  
Current Tax 85.80 98.14 144.63 157.63 101.54  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -12.73 6.59 4.34 6.72 3.62  
Tax For Earlier Years 6.57 -0.78 -2.17 0.00 0.18  
Total Tax Expenses 79.64 103.96 146.79 164.35 105.33  
Profit/Loss After Tax And Before ExtraOrdinary Items 271.71 304.82 432.60 558.10 308.65  
Profit/Loss From Continuing Operations 271.71 304.82 432.60 558.10 308.65  
Profit/Loss For The Period 271.71 304.82 432.60 558.10 308.65  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 10.67 11.97 16.99 21.92 12.12  
Diluted EPS (Rs.) 10.62 11.97 16.99 21.92 12.12  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 0.00 0.00 203.65 101.83 25.46  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 0.00 0.00 600.00 500.00 200.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970